Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL3643961 | 0.97 | TSHR (0.47) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL15348669 | 0.94 | TSHR (0.44) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL27869205 | 0.87 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL36704 | 0.87 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL36703 | 0.87 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL331298 | 0.84 | TSHR (0.53) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL331297 | 0.84 | TSHR (0.53) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3643964 | 0.84 | TSHR (0.53) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28602156 | 0.84 | TSHR (0.53) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL331443 | 0.84 | TSHR (0.53) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079810-A | Aromatic diamine and polyimide containing amido, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122071633-A | Stratum working fluid and system for viscosity reduction of thickened oil, and preparation method and application thereof | 中国石油天然气股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| CN-119308134-B | Modified carbon fiber, carbon fiber reinforced composite coating, and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-19 | — | — | CN | claimed |
| CN-118515247-B | High-stability organophosphorus functionalized black phosphorus nanosheet dispersion liquid and preparation method thereof | 华南理工大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | ENTEGRIS INC (US) | 2026-01-15 | — | — | US | claimed |
| US-12459913-B2 | Preparation of substituted pyrazoles and their use as anthranilamides precursors | ADAMA MAKHTESHIM LTD. (IL) | 2025-11-04 | — | — | US | claimed |
| EP-3904451-B1 | POLYVINYLIDENE FLUORIDE RESIN COMPOSITION AND MOLDED BODY | KUREHA CORP (JP) | 2025-08-27 | — | — | EP | claimed |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | ADAMA MAKHTESHIM LTD. (IL) | 2025-05-29 | — | — | US | claimed |
| CN-120006305-A | Method for preparing aromatic ketone compound by electrochemical micro-channel continuous flow oxidation of alkyl aromatic hydrocarbon | 南京工业大学 | 2025-05-16 | — | — | CN | claimed |
| CN-113874356-B | Preparation of substituted pyrazoles and use thereof as precursors of anthranilamides | 安道麦马克西姆有限公司 | 2025-04-08 | — | — | CN | claimed |
| EP-0707022-A2 | Method for preparation of arylene vinylene polymers and electroluminescent device including same | AT&T Corp. (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0414506-B1 | Toner and developer compositions with charge enhancing additives | XEROX CORP (US) | 1995-12-13 | — | — | EP | claimed |
| EP-0600659-A1 | Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives | XEROX CORPORATION (US) | 1994-06-08 | — | — | EP | claimed |
| US-5304449-A | Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives | XEROX CORPORATION (US) | 1994-04-19 | — | — | US | claimed |
| EP-0414506-A1 | Toner and developer compositions with charge enhancing additives | XEROX CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |
| US-4937157-A | Toner and developer compositions with charge enhancing additives | XEROX CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| US-4904762-A | Toner compositions with charge enhancing additives | XEROX CORPORATION (US) | 1990-02-27 | — | — | US | claimed |
| US-4668349-A | Acid promoted electrocatalytic reduction of carbon dioxide by square planar transition metal complexes | THE STANDARD OIL COMPANY (US) | 1987-05-26 | — | — | US | claimed |
| US-4522729-A | CXONTACTING IMPORITIES WITH TETRAALKYLAMMONIUM SALT | PHILLIPS PETROLEUM COMPANY (US) | 1985-06-11 | — | — | US | claimed |
| US-3996078-A | ALKANOLAMINE NITRATE OR PERCHLORATE | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1976-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | DDT, IDO2, INSR | TSHR 407/4885NFKB1 1530/4885KCNA1 721/4885 |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | TET2, ASIC1, PIEZO1 | TSHR 2647/4885NFKB1 2500/4885KCNA1 585/4885 |
| US-12459913-B2 | Preparation of substituted pyrazoles and their use as anthranilamides precursors | CYP2F1, PPOX, CYP11B2 | TSHR 2521/4885NFKB1 1870/4885KCNA1 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.